Lymphoid neogenesis in murine cardiac allografts undergoing chronic rejection

被引:120
作者
Baddoura, FK [1 ]
Nasr, IW
Wrobel, B
Li, Q
Ruddle, NH
Lakkis, FG
机构
[1] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA
[2] Vet Affairs Med Ctr, Buffalo, NY USA
[3] Yale Univ, Sch Med, Dept Internal Med, Nephrol Sect, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
allograft rejection; lumphoid neogenesis; PNAd; tertiary lymphoid organs; transplantation;
D O I
10.1111/j.1600-6143.2004.00714.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Lymphoid neogenesis is the process by which ectopic lymphoid accumulations that resemble lymph nodes arise in nonlymphoid tissues. Such lymphoid accumulations, known as tertiary lymphoid organs (TLO), are observed in chronic autoimmunity and they propagate immune pathology by setting up local antigen presenting sites. Whether lymphoid neogenesis occurs in transplanted organs and contributes to rejection is not well understood. To begin to address this question, we retrospectively analyzed 319 murine cardiac allografts for microscopic evidence of lymph-node-like structures. We found 78 allografts that had either classical TLO, characterized by discrete T- and B-cell zones and high endothelial venules (HEV) expressing peripheral node addressin (PNAd) (n = 34), or PNAd(+) HEV without organized lymphoid accumulations (n = 44). These changes were present in both short- and long-lived allografts and were invariably associated with rejection. Importantly, they occurred in 78% of allografts undergoing chronic rejection (n = 85) but in only 7% of allografts undergoing primarily acute rejection (n = 184). These findings indicate that, like autoimmunity, alloimmunity is associated with lymphoid neogenesis in the target organ and suggest a role for local T- cell activation in chronic allograft rejection.
引用
收藏
页码:510 / 516
页数:7
相关论文
共 22 条
[1]  
Billingham M E, 1990, J Heart Transplant, V9, P587
[2]   The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response [J].
Chalasani, G ;
Li, Q ;
Konieczny, BT ;
Smith-Diggs, L ;
Wrobel, B ;
Dai, ZH ;
Perkins, DL ;
Baddoura, FK ;
Lakkis, FG .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7813-7820
[3]   Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts [J].
Ciubotariu, R ;
Liu, ZR ;
Colovai, AI ;
Ho, E ;
Itescu, S ;
Ravalli, S ;
Hardy, MA ;
Cortesini, R ;
Rose, EA ;
Suciu-Foca, N .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :398-405
[4]   PRIMARILY VASCULARIZED ALLOGRAFTS OF HEARTS IN MICE - ROLE OF H-2D, H-2K, AND NON-H-2 ANTIGENS IN REJECTION [J].
CORRY, RJ ;
WINN, HJ ;
RUSSELL, PS .
TRANSPLANTATION, 1973, 16 (04) :343-350
[5]   Ectopic LTαβ directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase [J].
Drayton, DL ;
Ying, XY ;
Lee, J ;
Lesslauer, W ;
Ruddle, NH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1153-1163
[6]   HIGH ENDOTHELIAL VENULES (HEVS) - SPECIALIZED ENDOTHELIUM FOR LYMPHOCYTE MIGRATION [J].
GIRARD, JP ;
SPRINGER, TA .
IMMUNOLOGY TODAY, 1995, 16 (09) :449-457
[7]   SULFATION-DEPENDENT RECOGNITION OF HIGH ENDOTHELIAL VENULES (HEV)-LIGANDS BY L-SELECTIN AND MECA-79, AN ADHESION-BLOCKING MONOCLONAL-ANTIBODY [J].
HEMMERICH, S ;
BUTCHER, EC ;
ROSEN, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06) :2219-2226
[8]   Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes [J].
Hemmerich, S ;
Bistrup, A ;
Singer, MS ;
van Zante, A ;
Lee, JK ;
Tsay, D ;
Peters, M ;
Carminati, JL ;
Brennan, TJ ;
Carver-Moore, K ;
Leviten, M ;
Fuentes, ME ;
Ruddle, NH ;
Rosen, SD .
IMMUNITY, 2001, 15 (02) :237-247
[9]  
Hjelmström P, 2001, J LEUKOCYTE BIOL, V69, P331
[10]  
Kirveskari J, 2000, J AM SOC NEPHROL, V11, P2358, DOI 10.1681/ASN.V11122358